In summary, the findings from this study are consistent with ADORA2B activity being important for tumor progression in at least a subset of breast cancer, providing a potential therapeutic target for the development of small molecule inhibitors for the treatment of this devastating disease. The gene discussed is ADORA2B; the disease is neoplasm.